Received Jan 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19-2 | COVID19 (COVID19 (MODERNA BIVALENT)) | MODERNA | UNK | — | — |
Contracted Covid in January of 2024/she tested positive too; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contracted Covid in January of 2024/she tested positive too) in a 43-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis. No Medical History information was reported. In January 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In January 2024, the patient experienced COVID-19 (Contracted Covid in January of 2024/she tested positive too). At the time of the report, COVID-19 (Contracted Covid in January of 2024/she tested positive too) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2024, SARS-CoV-2 test: Positive. Concomitant medication use information was not provided by reporter. The vaccines received within the past 4 weeks were reported as unknown. Treatment medication use information was not provided by reporter. This case was linked to US-MODERNATX, INC.-MOD-2026-793303 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2026-793303:Mater case (Same reporter different patient:)
Test Date: 202401; Test Name: COVID-19 Virus test; Test Result: Positive